MELD fails to measure quality of life in liver transplant candidates
Sammy Saab, Ayman B. Ibrahim, Alexander Shpaner, Zobair M. Younossi, Cindy Lee, Francisco Durazo, Steven Han, Karl Esrason, Victor Wu, Jonathan Hiatt, Douglas G. Farmer, R. Mark Ghobrial, Curtis Holt, Hasan Yersiz, Leonard I. Goldstein, Myron J. Tong, Ronald W. Busuttil – 21 January 2005 – Previous studies have demonstrated an association between Child Turcotte‐Pugh (CTP) class and impaired quality of life. However, the relationship between the model for end‐stage liver disease (MELD) score and quality of life (QOL) has not been well studied.